Real-time trade and investing ideas on Agenus Inc. AGEN from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. AGEN Stock Price, Forecast & News (Agenus) | MarketBeat Agenus Inc (NASDAQ:AGEN) announced its earnings results on Thursday, August, 8th. The biotechnology company reported ($0.38) EPS for the quarter, missing analysts' consensus estimates of ($0.33) by $0.05. The biotechnology company had revenue of $15.72 million for the quarter, AGEN: Agenus Inc - Stock Price, Quote and News - CNBC Get Agenus Inc (AGEN:NASDAQ) real-time stock quotes, news and financial information from CNBC. AGEN | Agenus Inc. Stock Price & News - WSJ View the latest Agenus Inc. (AGEN) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Agenus Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update March 12, 2020 First QS-21 Royalty Payment Due to Agenus is Triggered March 10, 2020 To Cure Cancers
Investors – Agenus Mar 12, 2020 · Description tag: Agenus is an immuno-oncology company focused on the discovery and development of revolutionary treatments that engage the body’s immune system to benefit patients suffering from cancer AGEN Stock Analysis: Price, Forecast, and News AGEN Stock Analysis Overview . What this means: Agenus Inc (AGEN) gets an Overall Rank of 56, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.
Agenus Inc. Common Stock (AGEN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Agenus (AGEN) Stock Message Board - InvestorsHub AGEN News: Agenus to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020 with Conference Call and Webcast 03/03/2020 08:00:00 AM AGEN News: Agenus Announces Positive Interim Data from Balstilimab and Zalifrelimab Clinical Trials in Second-Line Cervical Cancer Agenus Inc. (AGEN) Stocktalk | Seeking Alpha 1 million granted for QS21 vaccine adjuvant by Bill & Melinda Gates Foundation is not a lot of money but it is a huge endorsement for the Co. science. AGEN Stock Price and Chart — NASDAQ:AGEN — TradingView Moving Average indicator is applied to the Agenus Inc. (AGEN) chart. We can see the indicator acting as support line (green arrows), confirming the uptrend of chart, and also acting as resistance line (red arrows), confirming downtrend. When the chart cross the MA line, there is a change in trend.
Agenus Inc. - NASDAQ:AGEN - Stock Quote & News - TheStreet
Agenus' Stock Up 23% on Immuno-Oncology Deal With Gilead. Dec 20, 2018. Mid-Day Market Update: Crude Oil Down Over 3%; Agenus Shares Spike Higher. Dec 20, 2018 Agenus Inc. (AGEN) Stock Analysis & News | Seeking Alpha Get breaking news and analysis on Agenus Inc. (AGEN) stock, price quote and chart, trading and investing tools. Get breaking news and analysis on Agenus Inc. (AGEN) stock, price quote and chart Agenus - AGEN - Stock Price & News | The Motley Fool
AGEN Stock Price Quote & News - Agenus | Robinhood
Agenus Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update March 12, 2020 First QS-21 Royalty Payment Due to Agenus is Triggered March 10, 2020 To Cure Cancers AGEN Price Target and Analyst Ratings (Agenus) | MarketBeat Nov 08, 2019 · Their average twelve-month price target is $6.00, suggesting that the stock has a possible upside of 159.74%. The high price target for AGEN is $6.00 and the low price target for AGEN is $6.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy." AGEN | Stock Snapshot - Fidelity
AGEN Stock Price | Agenus Inc. Stock Quote (U.S.: Nasdaq ...